AI Tool Comparison
Comparing as AI Remote Patient MonitoringCadence vs Teladoc Health
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Cadence
VS

Teladoc Health
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Cadence
Teladoc Health
Pricing
EnterpriseCadence is an enterprise-only platform with no public pricing. All deployments are custom contracts negotiated directly with health systems and payers.
Many Cadence programs are Medicare-reimbursable: Remote Patient Monitoring (RPM) codes and Advanced Primary Care Management (APCM) codes for qualifying Medicare patients provide a reimbursement pathway that reduces net cost for health systems. Published ROI data shows a 3:1 return to Medicare for every dollar spent.
Contact Cadence through cadence.care for health system partnership and pricing discussions.
CustomTeladoc Health's Integrated Care is priced through enterprise B2B contracts with employers and health plans under per-member-per-month or visit-based arrangements. Most members access Teladoc through employer benefits or health insurance at no additional out-of-pocket cost.
BetterHelp direct-to-consumer therapy starts at approximately $65-$100/week billed monthly, depending on location and therapist. Insurance coverage is expanding with $90M-$105M in BetterHelp insurance revenue targeted for 2026.
Hospital technology and enterprise Integrated Care require direct contract negotiation. Contact Teladoc through teladochealth.com for enterprise and employer pricing.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
Summary
Clinical AI with supervised agents for chronic disease care — 27% fewer admissions, 3:1 Medicare ROI
World's largest virtual care platform — telehealth, BetterHelp, chronic care, and Pulse AI for 100M+ members
Cadence Pros & Cons
Pros
- Supervised AI agents automate high-volume chronic care tasks under physician oversight — unique clinical AI approach
- $100M Series C (June 2026) at $1.23B valuation — Spark Capital-backed with strong financial momentum
- 27% reduction in hospital admissions, $1,302 lower annual care cost per patient — peer-reviewed outcomes
- 3:1 Medicare ROI published — stronger economic validation than most RPM competitors
- Medicare RPM and APCM reimbursement support — reduces net cost burden on health systems
- Outcomes consistent across rural and underserved communities — proven equity in care access
- Hybrid AI + human clinical team model — AI amplifies clinicians rather than replacing them
Cons
- Enterprise health system sales cycle is long — not accessible to individual practices or small clinics
- No public pricing — all contracts custom negotiated with health systems
- Currently focused on seniors/Medicare population — less suited for younger patient populations
- 90,000+ patient scale is growing but still smaller than Teladoc or Biofourmis
- Dependent on Medicare reimbursement rates — policy changes could impact economics
- AI agents require ongoing physician supervision — not fully autonomous
Teladoc Health Pros & Cons
Pros
- World's largest virtual care company — 100M+ US members, $2.53B 2025 revenue, NYSE: TDOC
- Broadest portfolio: urgent care, chronic care, mental health, expert opinions, and hospital tech in one platform
- Pulse AI connects claims, devices, pharmacy, and medical records for targeted whole-person care
- 1.27M chronic care enrollees (Q2 2026) — proven scale in diabetes and cardiometabolic management
- BetterHelp — world's largest online therapy platform scaling insurance coverage
- Teladoc One (July 2026) — multidisciplinary care integrating chronic, mental health, and urgent care
- 20+ year public company track record — financial stability and enterprise credibility
Cons
- BetterHelp revenue declining — cash-pay mental health business under pressure from insurance transition
- Stock significantly below 2021 highs — company navigating business model shift to visit-based revenue
- Chronic care enrollment growth slower than expected vs ambitious targets
- Not a dedicated RPM platform — remote monitoring less specialized than Biofourmis or Current Health
- Consumer BetterHelp and enterprise Integrated Care operate largely separately
- Complex product portfolio can be difficult to navigate for smaller employer clients